Literature DB >> 12724373

Immunological and genetic characterization of Borrelia burgdorferi BapA and EppA proteins.

Jennifer C Miller1, Brian Stevenson.   

Abstract

A large majority of examined Lyme disease spirochaete isolates were demonstrated to contain one or both of the paralogous genes bapA and eppA. Immunological analyses of serum samples collected from infected patients coupled with comparative sequence analyses indicated that bapA gene sequences are quite stable but the encoded proteins do not provoke a strong immune response in most individuals. Conversely, EppA proteins are much more antigenic but vary widely in sequence between different bacteria. Considerable evidence of insertion, deletion and other mutations within eppA genes was observed. A number of significant recombination events were also found to have occurred in regions flanking bapA genes, while the genes themselves rarely exhibited evidence of mutation, suggesting strong selective pressure to maintain BapA sequences within narrow limits. Data from these and other studies suggest important roles for BapA and EppA during the Borrelia burgdorferi infectious cycle.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12724373     DOI: 10.1099/mic.0.26120-0

Source DB:  PubMed          Journal:  Microbiology        ISSN: 1350-0872            Impact factor:   2.777


  8 in total

1.  Distribution of cp32 prophages among Lyme disease-causing spirochetes and natural diversity of their lipoprotein-encoding erp loci.

Authors:  Dustin Brisson; Wei Zhou; Brandon L Jutras; Sherwood Casjens; Brian Stevenson
Journal:  Appl Environ Microbiol       Date:  2013-04-26       Impact factor: 4.792

2.  Borrelia burgdorferi BBB07 interaction with integrin alpha3beta1 stimulates production of pro-inflammatory mediators in primary human chondrocytes.

Authors:  Aruna K Behera; Enrique Durand; Carla Cugini; Styliani Antonara; Lori Bourassa; Ethan Hildebrand; Linden T Hu; Jenifer Coburn
Journal:  Cell Microbiol       Date:  2007-09-06       Impact factor: 3.715

3.  Borrelia burgdorferi complement regulator-acquiring surface protein 2 (CspZ) as a serological marker of human Lyme disease.

Authors:  Peter Kraiczy; Annekatrin Seling; Catherine A Brissette; Evelyn Rossmann; Klaus-Peter Hunfeld; Tomasz Bykowski; Logan H Burns; Matthew J Troese; Anne E Cooley; Jennifer C Miller; Volker Brade; Reinhard Wallich; Sherwood Casjens; Brian Stevenson
Journal:  Clin Vaccine Immunol       Date:  2007-12-26

4.  A genome-wide proteome array reveals a limited set of immunogens in natural infections of humans and white-footed mice with Borrelia burgdorferi.

Authors:  Alan G Barbour; Algimantas Jasinskas; Matthew A Kayala; D Huw Davies; Allen C Steere; Pierre Baldi; Philip L Felgner
Journal:  Infect Immun       Date:  2008-05-12       Impact factor: 3.441

5.  Intra- and interbacterial genetic exchange of Lyme disease spirochete erp genes generates sequence identity amidst diversity.

Authors:  Brian Stevenson; Jennifer C Miller
Journal:  J Mol Evol       Date:  2003-09       Impact factor: 2.395

6.  The borrelial fibronectin-binding protein RevA is an early antigen of human Lyme disease.

Authors:  Catherine A Brissette; Evelyn Rossmann; Amy Bowman; Anne E Cooley; Sean P Riley; Klaus-Peter Hunfeld; Michael Bechtel; Peter Kraiczy; Brian Stevenson
Journal:  Clin Vaccine Immunol       Date:  2009-12-23

7.  Genome stability of Lyme disease spirochetes: comparative genomics of Borrelia burgdorferi plasmids.

Authors:  Sherwood R Casjens; Emmanuel F Mongodin; Wei-Gang Qiu; Benjamin J Luft; Steven E Schutzer; Eddie B Gilcrease; Wai Mun Huang; Marija Vujadinovic; John K Aron; Levy C Vargas; Sam Freeman; Diana Radune; Janice F Weidman; George I Dimitrov; Hoda M Khouri; Julia E Sosa; Rebecca A Halpin; John J Dunn; Claire M Fraser
Journal:  PLoS One       Date:  2012-03-14       Impact factor: 3.240

8.  Whole genome sequence and comparative analysis of Borrelia burgdorferi MM1.

Authors:  Neda Jabbari; Gustavo Glusman; Lena M Joesch-Cohen; Panga Jaipal Reddy; Robert L Moritz; Leroy Hood; Christopher G Lausted
Journal:  PLoS One       Date:  2018-06-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.